Literature DB >> 22416833

A Bayesian inference of P(π1 > π2) for two proportions.

Youhei Kawasaki1, Etsuo Miyaoka.   

Abstract

The statistical inference concerning the difference between two independent binominal proportions is often discussed in medical and statistical literature. However, such discussions are often based on the frequentist viewpoint rather than the Bayesian viewpoint. In this article, we propose an index θ =P(π(1, post ) > π(2, post )), where π(1, post ) and π(2, post ) denote binominal proportions following posterior density. We provide approximate and exact expressions for θ by using the beta prior. We also present the results of actual clinical trials to show the utility of θ. Our findings suggest that θ can potentially provide useful information in a clinical trial.

Entities:  

Mesh:

Year:  2012        PMID: 22416833     DOI: 10.1080/10543406.2010.544438

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  5 in total

1.  Building efficient comparative effectiveness trials through adaptive designs, utility functions, and accrual rate optimization: finding the sweet spot.

Authors:  Byron J Gajewski; Scott M Berry; Melanie Quintana; Mamatha Pasnoor; Mazen Dimachkie; Laura Herbelin; Richard Barohn
Journal:  Stat Med       Date:  2015-01-07       Impact factor: 2.373

2.  Simulation optimization for Bayesian multi-arm multi-stage clinical trial with binary endpoints.

Authors:  Zhenning Yu; Viswanathan Ramakrishnan; Caitlyn Meinzer
Journal:  J Biopharm Stat       Date:  2019-02-14       Impact factor: 1.051

3.  Influence of Institution-Based Factors on Preoperative Blood Testing Prior to Low-Risk Surgery: A Bayesian Generalized Linear Mixed Approach.

Authors:  Kazuki Ide; Hiroshi Yonekura; Yohei Kawasaki; Koji Kawakami
Journal:  Comput Math Methods Med       Date:  2017-12-07       Impact factor: 2.238

4.  Hypothesis testing in Bayesian network meta-analysis.

Authors:  Lorenz Uhlmann; Katrin Jensen; Meinhard Kieser
Journal:  BMC Med Res Methodol       Date:  2018-11-12       Impact factor: 4.615

5.  Evaluation of a multi-arm multi-stage Bayesian design for phase II drug selection trials - an example in hemato-oncology.

Authors:  Louis Jacob; Maria Uvarova; Sandrine Boulet; Inva Begaj; Sylvie Chevret
Journal:  BMC Med Res Methodol       Date:  2016-06-02       Impact factor: 4.615

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.